- Home
- ICCC vs NDLS Comparison
ICCC vs NDLS Comparison
Compare ICCC & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- NDLS
- Stock Information
- Founded
- ICCC 1982
- NDLS 1995
- Country
- ICCC United States
- NDLS United States
- Employees
- ICCC N/A
- NDLS N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- ICCC Health Care
- NDLS Consumer Discretionary
- Exchange
- ICCC Nasdaq
- NDLS Nasdaq
- Market Cap
- ICCC 46.2M
- NDLS 45.2M
- IPO Year
- ICCC 1987
- NDLS 2013
- Fundamental
- Price
- ICCC $6.83
- NDLS $0.79
- Analyst Decision
- ICCC
- NDLS Strong Buy
- Analyst Count
- ICCC 0
- NDLS 2
- Target Price
- ICCC N/A
- NDLS $3.00
- AVG Volume (30 Days)
- ICCC 27.2K
- NDLS 200.5K
- Earning Date
- ICCC 05-14-2025
- NDLS 05-07-2025
- Dividend Yield
- ICCC N/A
- NDLS N/A
- EPS Growth
- ICCC N/A
- NDLS N/A
- EPS
- ICCC N/A
- NDLS N/A
- Revenue
- ICCC $27,302,766.00
- NDLS $495,670,000.00
- Revenue This Year
- ICCC N/A
- NDLS $5.37
- Revenue Next Year
- ICCC N/A
- NDLS $0.68
- P/E Ratio
- ICCC N/A
- NDLS N/A
- Revenue Growth
- ICCC 28.29
- NDLS N/A
- 52 Week Low
- ICCC $3.34
- NDLS $0.55
- 52 Week High
- ICCC $6.95
- NDLS $2.20
- Technical
- Relative Strength Index (RSI)
- ICCC 74.94
- NDLS 45.68
- Support Level
- ICCC $6.00
- NDLS $0.71
- Resistance Level
- ICCC $6.95
- NDLS $0.85
- Average True Range (ATR)
- ICCC 0.39
- NDLS 0.08
- MACD
- ICCC 0.12
- NDLS 0.01
- Stochastic Oscillator
- ICCC 94.12
- NDLS 49.92
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.